Over the past 20 years, significant advancements in stem cell research and therapies have made it one of the most promising methods of creating new insulin making cells needed to cure Type 1 diabetes.

Vertex Pharmaceuticals recently released data from a clinical trial in which the company showed it was able to restore a Type 1 diabetic’s ability to make insulin.

Other companies are also working toward a cure, including ViaCyte, CRISPR, and Novo Nordisk.

WATCH MORE: https://thestartv.com/c/news
SUBSCRIBE: https://cutt.ly/TheStar
LIKE: https://fb.com/TheStarOnline

Leave a Reply

Your email address will not be published. Required fields are marked *